Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Aalborg – page 22

330 clinical trials in Aalborg, Denmark across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Aalborg at a glance
330
clinical trials
  • Research sites4
Type of trial
Recruitment status
Quick filters

330 trials in Aalborg

Open in trial search

Back pain

Not recruiting

Study on Gabapentin for Treating Nerve Pain in the Leg from Lower Back Pain

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Gabapentin
  • Sponsor:Rigshospitalet

Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Janssen Cilag International

Colorectal cancer

Not recruiting

Study for Patients with Metastatic Colorectal Cancer with BRAF V600E Mutation Using Encorafenib, Cetuximab, and Chemotherapy Combination

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Pfizer Inc.

Incontinence+1

Not recruiting

Study on Stopping Solifenacin and Mirabegron for Children with Daytime Urinary Incontinence

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Mirabegron
  • Sponsor:Region Midtjylland

Dermatitis atopic

Not recruiting

Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:IO102 hydrochloride
  • Sponsor:Io Biotech ApS

Adenocarcinoma gastric+1

Not recruiting

Study of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Dermatitis atopic

Not recruiting

Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.

Ovarian cancer

Not recruiting

Study on Niraparib for Maintenance Treatment in Patients with Advanced Ovarian Cancer After Initial Chemotherapy Response

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Niraparib Tosilate Monohydrate
  • Sponsor:Tesaro Inc.

Pneumonia

Not recruiting

Study on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin
  • Sponsor:Insmed Inc.

Study on the Safety and Effectiveness of Epcoritamab, Venetoclax, and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Genmab A/S

Study on the Effects of Itepekimab on Airway Inflammation in Former Smokers with Chronic Obstructive Pulmonary Disease (COPD)

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Aalborg

What the registry says about research in the country

01 Oncology Studies

Innovative research focusing on endometrial cancer and metastatic prostate cancer treatments. Studies evaluating new therapeutic combinations and investigating cannabidiol's potential in cancer care.

  • Advanced breast cancer therapy evaluation
  • Cancer-related fatigue management
  • Novel drug combinations assessment

Multiple trials exploring targeted therapies and quality of life improvements for cancer patients.

02 Immunology & Infectious Diseases

Comprehensive studies on meningococcal vaccines and chickenpox prevention in children. Research includes RSV prevention and inflammatory conditions.

  • Vaccine immunogenicity studies
  • Chronic rhinosinusitis treatments
  • Plaque psoriasis therapies

Focus on preventive medicine and immune system responses in various age groups.

03 Gastrointestinal & Metabolic Disorders

Investigations into inflammatory bowel diseases including studies on Crohn's Disease and Ulcerative Colitis. Research on opioid-induced bowel dysfunction.

  • Therapeutic drug monitoring
  • Bowel dysfunction treatments
  • Novel therapeutic combinations

Advancing understanding of digestive system disorders and their management.

04 Cardiovascular & Renal Studies

Research on chronic kidney disease treatments and heart failure prevention. Studies examining new approaches for cardiovascular disease management.

  • Heart failure prevention strategies
  • Kidney disease therapies
  • Cardiovascular risk reduction

Innovative approaches to managing complex cardio-renal conditions.

05 Neurological & Psychiatric Research

Studies investigating treatments for amyotrophic lateral sclerosis and dual diagnosis of schizophrenia with alcohol use disorder.

  • ALS treatment development
  • Psychiatric disorder management
  • Neurological disease therapies

Exploring new therapeutic options for complex neurological and psychiatric conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.